Source map — Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEs
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Fierce Biotech | news | 60% |
| Reuters | news | 60% |
| Business Wire | news | 60% |
| Endpoints News | news | 60% |
| FirstWord Pharma | news | 60% |
| insights.citeline.com | news | 60% |
| finance.yahoo.com | news | 50% |
| www.nbcnews.com | news | 50% |
| www.talk.bio | news | 50% |
| www.biospace.com | news | 50% |